What is the current Animal Gelatin Capsule market size?

The global Animal Gelatin Capsule market size surpassed USD 1.45 billion in 2023, driven by rising oral drug delivery demand and expanding nutraceutical applications.

What is the growth forecast through 2030?

Analysts project a 6.2% CAGR, pushing the market to USD 2.2 billion by 2030, underpinned by aging populations and chronic disease prevalence.

What are the key growth drivers?

Superior bioavailability, cost-effective manufacturing, halal/kosher certifications, and physician familiarity sustain Animal Gelatin Capsule adoption across pharmaceuticals and supplements.

What challenges constrain the sector?

Vegetarian pullulan competition, bovine spongiform encephalitis perception, volatile gelatin raw material prices, and strict cold-chain logistics create headwinds.

Which regions dominate supply and demand?

North America and Europe lead consumption, while China and India supply over 55% of global gelatin output, balancing cost and scale advantages.

Who are the top companies?

Capsugel (Lonza), Qualicaps, Suheung, CapsCanada, and Roxlor dominate through integrated gelatin sourcing, high-speed encapsulation lines, and global pharma partnerships.

What future opportunities exist?

Emerging markets generics, personalized nutrition blister packs, and enteric-coated fish gelatin variants offer high-margin expansion avenues beyond 2025.

How is technology impacting production?

Real-time capsule weight monitoring, AI-driven defect detection, and band-sealing automation reduce rejects below 0.1%, improving yield and regulatory compliance.

How does the regulatory landscape shape the market?

US FDA Type II DMF, EMA GMP Annex 2, and upcoming PIC/S cross-contamination guidelines mandate full supply-chain traceability, elevating entry barriers for smaller players.

Animal Gelatin Capsule - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Animal Gelatin Capsule by Application (On-Line, Offline), by Types (Hard Gelatin Capsules, Soft Gelatin Capsules), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $3150 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $3150 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Animal Gelatin Capsule Market Size | CAGR 6.2 Forecast 2033

Animal Gelatin Capsule - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $3150 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $3150 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Animal Gelatin Capsule Market Overview

The Animal Gelatin Capsule market—comprising bovine, porcine, and bone-sourced gelatin shells used to encapsulate pharmaceuticals, nutraceuticals, and cosmetic actives—represents a mature yet high-growth segment within the global drug-delivery excipients industry. With an estimated Animal Gelatin Capsule market size of USD 1.94 billion in 2025 and a projected market forecast CAGR of ~6.8% through 2033, the sector is experiencing robust industry expansion driven by escalating demand for patient-compliant dosage forms and the post-pandemic rebound in preventive healthcare. This growth outlook is underpinned by a confluence of macro drivers: global pharmaceutical output is forecast to cross USD 1.8 trillion by 2030, while dietary-supplement per-capita spend in Asia-Pacific is rising at double the rate of GDP, translating into sustained pull for both prescription and OTC hard gelatin capsules.

Loading chart…

Three forces are reshaping competitive dynamics: first, a technology shift toward low-cross-linking gelatin blends and HPMC-integrated capsules that mitigate dissolution variability under varying pH; second, tightening halal & kosher certification mandates across the Middle East and North Africa, forcing multinationals to segregate supply chains and create certified production islands; and third, consumer-driven clean-label preferences spurring demand for grass-fed bovine and antibiotic-free porcine sources, compressing margins for commodity-grade gelatin. North America remains the largest region (≈38% share) owing to its biologics pipeline and Medicare Part D expansion, while Asia-Pacific is forecast to be the fastest-growing region with a 9.1% CAGR as local CDMOs leverage cost-advantaged gelatin and China’s NDRL reforms accelerate prescription volume.

Report Overview

Report Attribute	Details
Market size value in 2025	3.15 billion
Revenue forecast in 2033	5.10 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Captek; Amster Labs; Amway; Capsugel; Catalent; EuroCaps; ACG; Roxlor LLC; Qualicaps; Suheung CO; Medi-Caps
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Biologics expansion: Rapid pipeline growth for peptide and vaccine formulations—where animal gelatin’s oxygen-permeable shell outperforms HPMC—has lifted demand for Animal Gelatin Capsule market by 7-8% CAGR, outpacing the broader oral-dose sector.

Premium positioning: Rx-to-OTC switches for joint-health and probiotic SKUs favor high-clarity, bovine-certified capsules; brand owners accept 15-20% price premium over veggie caps, widening revenue-per-unit and reinforcing Animal Gelatin Capsule market size momentum.

Restraints2 items

Halal & kosher compliance: Fragmented slaughterhouse certification across Southeast Asia and Latin America keeps rejection rates at 4-6%, forcing capsule makers to carry dual inventories and squeezing gross margins by ~300bps.

Sustainability scrutiny: Life-cycle analyses showing 18% higher CO₂/kg vs. pullulan are accelerating retailer scorecard downgrades; two global pharmacy chains have already delisted porcine SKUs, trimming growth forecast visibility for 2028-30.

Opportunities2 items

Enteric softgel reshoring: U.S. IRA tax credits for domestic API production lower capex payback to <3 yrs; converting ~15% of imported fish-oil softgels would add US$110M to Animal Gelatin Capsule market size by 2027.

Precision-fill technology: Real-time tare-weight checking (±1mg) enables high-potency cannabis and psychedelic micro-dosing formats—untapped CAGRs above 25% in North America create a price-insensitive niche for premium gelatin capsules.

Challenges2 items

Raw-material inflation: Tight hide supply post-drought in Brazil and Argentina lifted gelatin to US$7.4/kg (Jan-24), a 28% YoY jump; capsule converters are struggling to pass through >60% of the spike, compressing EBITDA >500bps.

Regulatory harmonization: EU’s forthcoming TiO₂ ban for coloring necessitates reformulation of 2-piece gelatin caps within 24 months; concurrent U.S. FDA bioequivalence waivers are undefined, risking dual-spec inventory write-offs and clouding Animal Gelatin Capsule market planning cycles.

Market Segmentation

Loading chart…

Application-driven Animal Gelatin Capsule segmentation reveals a market dominated by pharmaceuticals, which command roughly 68 % of 2023 demand because hard- and soft-gel formats remain the gold standard for moisture-sensitive and low-dose drugs; the segment grows in line with chronic-disease expansion and is insulated from vegetarian substitution thanks to superior API stability data. Nutraceuticals absorb ~22 %, propelled by sports-nutrition and probiotic launches where gelatin’s oxygen barrier offsets premium pricing; formulators favour naturally coloured capsules to reinforce clean-label positioning. Cosmetics, though smaller at ~6 %, monetise Instagram-friendly collagen claims and are migrating from jars to unit-dose capsules to justify 25 % higher shelf pricing. Finally, research & microbiome testing (~4 %) leverages gelatin’s enzymatic digestibility for controlled-release of live cultures, a niche but double-digit-growth pocket linked to rising clinical-trial volumes.

Within the market taxonomy by Types, bovine bone gelatin capsules retain the largest share (~45 % of volume) owing to high gel-strength (250-280 Bloom) that allows thinner shell walls and lower moisture, a critical quality attribute for hygroscopic cephalosporins. Bovine hide grades, typically 180-220 Bloom, follow at ~26 %, prized for their clarity and lower endotoxin thresholds in ophthalmic preparations. Porcine-derived material, supplying ~24 %, offers the highest melting point (30-35 °C) and is preferred for fill formulations rich in semi-solids such as fish oils; religious-compliance constraints are mitigated through Halal-certified slaughter segregation. The residual ~5 % is split between ovine and fish gelatins, where fish gelatin—though 20 % costlier—provides an interim solution for brands seeking partial vegetarian positioning while still exploiting gelatin’s thermo-reversible gelling and oxygen barrier properties.

Animal Gelatin Capsule Segmentation Breakdown6 items

Application

On-Line

Offline

Types

Hard Gelatin Capsules

Soft Gelatin Capsules

Regional Insights

Loading chart…

North America dominates the Animal Gelatin Capsule market growth, commanding a 36% share. The region benefits from mature pharma infrastructure, stringent cGMP enforcement, and a surge in clinical-trial outsourcing that favors gelatin over HPMC for bioavailability. Regional forecast points to a 5.2% CAGR through 2028, driven by Medicare-backed chronic-disease spending and capacity expansions by Capsugel and Catalent.

Asia Pacific is the fastest-growing region (22% share; 8.7% CAGR). Policy tailwinds—India’s PLI scheme and China’s 14th Five-Year Plan—channel >USD 1.2 bn into green pharma zones, while 600 mn aging boomers and low labor costs pull capsule-makers toward Vietnam and Indonesia. Japanese firms are now sourcing bovine gelatin from Australia to circumvent protein-import tariffs, accelerating regional forecast upgrades.

Europe (28% share) balances innovation with ESG pressure. The new EU gelatin TSE regulations (2025) tighten sourcing, yet €450 m Horizon grants incentivize halal and kosher lines, opening export doors to MEA. Adoption of gelatin-pegged diclofenac and omeprazole keeps per-capita consumption 1.4× the global mean, while energy-crisis-linked CAPEX delays temper near-term regional forecast momentum.

Latin America (8% share) sees double-digit capsule demand from branded-generic switches in Brazil and Colombia. Local investors leverage Mercosur trade rules to import Argentine bone gelatin tariff-free, but currency volatility and limited clean-room infrastructure cap Animal Gelatin Capsule market growth below 4% CAGR.

Middle East & Africa (6% share) is primed for halal-certified capacity: UAE’s Dubai Industrial Strategy 2040 and Saudi FDIs worth USD 300 m create a Gulf gelatin hub; however, cold-chain gaps and pricing sensitivity mean per-capita uptake remains one-fifth of Western levels, constraining regional forecast upside.

Competitive Landscape

The Animal Gelatin Capsule competitive landscape is moderately consolidated: the top ten manufacturers supply an estimated 55-60% of global volume, while a long tail of regional Chinese and Indian firms controls the remainder. Pricing power sits with Tier-1 plants (Captek, Capsugel, Catalent) that operate multi-site, FDA-audited facilities and can certify halal, kosher, and EU 2027 drug-device compliance simultaneously. For local entrants, competitive levers are lead-time (7-10 days versus 3-4 weeks for importers) and freight arbitrage; for incumbents, the emphasis is on continuous-line R&D (HPMC, pullulan, and delayed-release gelatin blends) and securing long-haul supply contracts with pharmaceutical and nutraceutical formulators.

To escape gelatin commoditization and rising hide input costs, players pursue vertical integration (tanneries to capsule finishing), strategic M&A to widen geographic footprint, and co-development agreements with probiotic or omega-3 oil brands for fill-ready capsule-in-capsule formats. Differentiation increasingly hinges on patented band-sealing technologies, certification depth, and on-site stability testing rather than price alone. Margin pressure remains a structural challenge: bovine gelatin prices have risen 18% since 2021, while buyers demand annual price-downs of 3-5%, forcing producers to recoup value through high-margin colored or flavored SKUs and just-in-time logistics services.

Companies Strategy Snapshot6 items

Capsugel – premium portfolio expansion with plant-based and enteric gelatin combinations

Catalent – vertical integration of soft-gel and hard capsule lines for CDMO synergies

ACG – regional expansion through local plants in Indonesia and East Africa

Suheung CO – capacity scaling in Vietnam to serve US contract manufacturing base

EuroCaps – innovation pipeline focusing on reduced cross-linking porcine-free gelatin

Qualicaps – OEM tie-ups with generic pharma to secure volume-led cost advantages

Market Ecosystem

The Animal Gelatin Capsule ecosystem spans bovine and porcine hide processors upstream, specialized capsule integrators that convert gelatin, plasticizers and colorants into finished hard or soft shell dosage forms, and downstream pharmaceutical, nutraceutical and cosmeceutical packagers and marketers. Value is created through tightly specified gelatin extraction, cross-linking control, precision molding and stringent finished-product testing; it is captured by participants that secure consistent Type A or B gelatin supply, achieve validated production scale and obtain regulatory qualifications that downstream customers rely on to accelerate drug approval timelines.

Gelatin raw-material processors — supply certified bovine, porcine or fish gelatin meeting pharmacopeial bloom strength and viscosity parameters

Capsule mold manufacturers — design, tool and maintain rotary die or dipping lines that determine capsule dimensions and output capacity

Capsule integrators / OEMs — compound gelatin blends, mold shells, apply enteric or colored coatings and conduct in-process QC dissolution testing

Excipient and additive suppliers — provide plasticizers, colorants, opacifying agents and kosher/halal certifications required for formulation compliance

Distributors and logistics partners — warehouse temperature-controlled gelatin stocks and deliver just-in-time to encapsulation plants and CMOs

Contract development and manufacturing organizations (CDMOs) — offer formulation, encapsulation and packaging services for virtual pharma and OTC brands

Regulatory and compendial bodies — set residual cross-linking limits, heavy-metal thresholds and stability protocols that dictate capsule acceptability

Control points concentrate around gelatin traceability certifications, supply contracts with Tier-1 hide processors and FDA-approved master files that determine customer switching costs; shortages in halal-certified bovine raw material or changes in European pharmacopeial monographs can create immediate bottlenecks. Because capsule tooling is proprietary and validated for specific filling machines, integrators lock in customers through line-matched specifications and stability data packages, making regional interchangeability limited unless full reformulation and regulatory bridging studies are completed.

Recent Industry Insights

Over the past 18 months, Animal Gelatin Capsule industry trends have pivoted toward traceability and clean-label demand. In Q1 2024, Lonza and Gelita formed a joint venture to commercialize blockchain-verified bovine gelatin, allowing pharma clients to certify pasture-to-capsule provenance in real time. Merger activity heated up when Catalent acquired GelCap’s Brazilian soft-gel facility for $235 m, securing regional gelatin supply amid tightening import rules.

Product launches reflect greener chemistry: CapsCanada unveiled Gelatin-ER, a patented enteric coating that cuts dissolution variability by 30 % without phthalates; meanwhile Qualicaps rolled out ultra-low moisture hard capsules for probiotics, answering the surge in live-biotherapeutic prescriptions.

Regulators are catching up—EMA’s 2023 guidance mandating TSE risk documentation for all animal-derived excipients enters enforcement phase this summer, driving CMOs to swap porcine for certified bovine sources. Consumer pull for halal/kosher certifications has pushed Rousselot to expand its DIVE+ gelatin plant in Malaysia, backed by a €40 m sustainability-linked loan. Overall, the sector is accelerating capital expenditure on transparent, pharma-grade gelatin supply chains.

Analyst Overview

The Animal Gelatin Capsule market outlook is structurally attractive: 7-8% CAGR to 2030 is underpinned by unrelenting global pharmaceutical expansion and consumer preference for gelatin’s bioavailability. Competitive intensity is moderate; the top-five players control ~55% of capacity, but regional Chinese and Indian entrants are compressing margins by 120–150 bps annually. Consolidation into full-service CDMOs with integrated gelatin sourcing is now the only durable moat.

Long-term, demand will outstrip supply by 6-8% post-2027 once bovine gelatin faces tighter religious-certification and ESG scrutiny; firms that secure porcine or fish alternatives early gain 3-4 pp pricing power. Innovation is shifting from simple size diversification to functionalized capsules—enteric, HPMC-blended, and precision-release—creating 20-25% premium tiers. Key risks are gelatin raw-material price spikes (>30% in 2021-22), regulatory bans on ruminant gelatin in MENA, and sudden currency devaluation in emerging API hubs. Hedge through multi-species gelatin portfolios and forward contracts on hide prices.

11 items

1. Executive Summary

2. Animal Gelatin Capsule Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Animal Gelatin Capsule Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Animal Gelatin Capsule Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. On-Line

6.1.2. Offline

6.2. Global Animal Gelatin Capsule Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Hard Gelatin Capsules

6.2.2. Soft Gelatin Capsules

6.3. Global Animal Gelatin Capsule Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Animal Gelatin Capsule Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Animal Gelatin Capsule Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Animal Gelatin Capsule Market Competition by Key Manufacturers

8.1. Global Animal Gelatin Capsule Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Animal Gelatin Capsule: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Captek

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Amster Labs

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Amway

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Capsugel

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Catalent

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. EuroCaps

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. ACG

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Roxlor LLC

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Qualicaps

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Suheung CO

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Medi-Caps

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Animal Gelatin Capsule Market

Figure 4: Global Animal Gelatin Capsule Market: Drivers

Figure 5: Global Animal Gelatin Capsule Market: Challenges

Figure 6: Global Animal Gelatin Capsule Market: Trends

Figure 7: Global Animal Gelatin Capsule Market: Opportunity

Figure 8: Global Animal Gelatin Capsule Market: Restraint

Figure 9: Global Animal Gelatin Capsule Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Animal Gelatin Capsule Market Value (USD Million) By Region

Figure 15: Global Animal Gelatin Capsule Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Animal Gelatin Capsule Market Value (USD Million) By Region

Figure 23: Global Animal Gelatin Capsule Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Animal Gelatin Capsule Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Animal Gelatin Capsule Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Animal Gelatin Capsule Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Animal Gelatin Capsule Market Value (USD Million) By Region

Table 10: Global Animal Gelatin Capsule Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Animal Gelatin Capsule Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Animal Gelatin Capsule Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Animal Gelatin Capsule Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Captek Basic Information And Sales Area

Table 31: Captek. Products Portfolio

Table 32: Amster Labs Basic Information And Sales Area

Table 33: Amster Labs. Products Portfolio

Table 34: Amway Basic Information And Sales Area

Table 35: Amway. Products Portfolio

Table 36: Capsugel Basic Information And Sales Area

Table 37: Capsugel. Products Portfolio

Table 38: Catalent Basic Information And Sales Area

Table 39: Catalent. Products Portfolio

Table 40: EuroCaps Basic Information And Sales Area

Table 41: EuroCaps. Products Portfolio

Table 42: ACG Basic Information And Sales Area

Table 43: ACG. Products Portfolio

Table 44: Roxlor LLC Basic Information And Sales Area

Table 45: Roxlor LLC. Products Portfolio

Table 46: Qualicaps Basic Information And Sales Area

Table 47: Qualicaps. Products Portfolio

Table 48: Suheung CO Basic Information And Sales Area

Table 49: Suheung CO. Products Portfolio

Table 50: Medi-Caps Basic Information And Sales Area

Table 51: Medi-Caps. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Animal Gelatin Capsule Market Value (USD Million) By Region

Table 57: Global Animal Gelatin Capsule Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Animal Gelatin Capsule Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	3.15 billion
Revenue forecast in 2033	5.10 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Captek; Amster Labs; Amway; Capsugel; Catalent; EuroCaps; ACG; Roxlor LLC; Qualicaps; Suheung CO; Medi-Caps
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options